Rachayon, M.; Jirakran, K.; Sodsai, P.; Klinchanhom, S.; Sughondhabirom, A.; Plaimas, K.; Suratanee, A.; Maes, M.
In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls. Pharmaceuticals 2022, 15, 405.
https://doi.org/10.3390/ph15040405
AMA Style
Rachayon M, Jirakran K, Sodsai P, Klinchanhom S, Sughondhabirom A, Plaimas K, Suratanee A, Maes M.
In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls. Pharmaceuticals. 2022; 15(4):405.
https://doi.org/10.3390/ph15040405
Chicago/Turabian Style
Rachayon, Muanpetch, Ketsupar Jirakran, Pimpayao Sodsai, Siriwan Klinchanhom, Atapol Sughondhabirom, Kitiporn Plaimas, Apichat Suratanee, and Michael Maes.
2022. "In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls" Pharmaceuticals 15, no. 4: 405.
https://doi.org/10.3390/ph15040405
APA Style
Rachayon, M., Jirakran, K., Sodsai, P., Klinchanhom, S., Sughondhabirom, A., Plaimas, K., Suratanee, A., & Maes, M.
(2022). In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls. Pharmaceuticals, 15(4), 405.
https://doi.org/10.3390/ph15040405